GSK

Money-flow analysis registers 7.82/10, indicating robust fund inflows, particularly from small and extra-large orders, despite negative trends in medium and large blocks. Analyst sentiment is overwhelmingly bearish with a single Sell rating from Barclays. The combination of positive flow and negative analyst view creates a nuanced, watchful stance.